GenMont Biotech Incorporation (TPE:3164)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Genmont (China)	46.69M	40.21M	8.57M	-	-
Genmont (China) Growth	16.11%	369.18%	-	-	-
Genmont Biotech Inc.	354.54M	345.16M	309.45M	368.55M	427.93M
Genmont Biotech Inc. Growth	2.72%	11.54%	-16.04%	-13.88%	31.59%
Total	401.23M	385.37M	318.02M	368.55M	427.93M
Total Growth	4.11%	21.18%	-13.71%	-13.88%	31.59%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Taiwan	199.53M	191.42M	193.43M	211.27M	188.61M
Taiwan Growth	4.24%	-1.04%	-8.44%	12.01%	1.49%
Singapore	43.49M	69.60M	37.84M	-	-
Singapore Growth	-37.52%	83.94%	-	-	-
China	111.02M	78.43M	56.86M	112.57M	197.55M
China Growth	41.57%	37.92%	-49.49%	-43.02%	73.56%
Other	47.19M	45.93M	29.89M	44.70M	41.77M
Other Growth	2.74%	53.69%	-33.14%	7.03%	63.65%
Total	401.23M	385.37M	318.02M	368.55M	427.93M
Total Growth	4.11%	21.18%	-13.71%	-13.88%	31.59%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 12, 2026

Data Sources Report a data error